NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve The Unaudited Financial Results of the Company For The Quarter And Nine Months Ended December 31, 2023 NEULAND LABORATORIES LTD. - 524558 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
From Neuland To Aurionpro: Malabar Investments Founder's Five Stocks For Long-Term Investment
'The biggest worry is that markets are forward-looking and some of the positives are already priced in,' he said, pointing out that globally high valuations and a probable recession were also risks. NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel NEULAND LABORATORIES LTD. - 524558 - Intimation Of S&P Global ESG Score, 2023
As part of our enduring commitment to environmental, social and governance (ESG) efforts, we would like to inform that our Company was awarded a Corporate Sustainability Assessment (CSA) score of 58 out of 100 by S&P Global. The Company''s score placed it in 94th percentile among 348 companies considered as industry peers during 2023. NEULAND LABORATORIES LTD. - 524558 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Davuluri Ram Mohan Rao 